See more : Tah Tong Textile Co., Ltd. (1441.TW) Income Statement Analysis – Financial Results
Complete financial analysis of XWELL, Inc. (XWEL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of XWELL, Inc., a leading company in the Personal Products & Services industry within the Consumer Cyclical sector.
You may be interested
- Kawasaki Heavy Industries, Ltd. (7012.T) Income Statement Analysis – Financial Results
- Focus Universal Inc. (FCUV) Income Statement Analysis – Financial Results
- American Oncology Network, Inc. (AONC) Income Statement Analysis – Financial Results
- Portofino Resources Inc. (PFFOF) Income Statement Analysis – Financial Results
- Japan Airlines Co., Ltd. (JPNRF) Income Statement Analysis – Financial Results
XWELL, Inc. (XWEL)
About XWELL, Inc.
XWELL Inc., a health and wellness services company, provides spa services at airports. It operates through XpresSpa, XpresTest, Treat, and HyperPointe brands. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL Inc. in October 2022. XWELL Inc. is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 30.11M | 55.94M | 73.73M | 8.39M | 48.52M | 50.09M | 48.82M | 18.97M | 22.69M | 1.43M | 1.10M | 369.00K | 718.00K | 211.00K | 20.00K | 0.00 |
| Cost of Revenue | 26.43M | 43.89M | 41.30M | 11.98M | 37.85M | 39.45M | 39.34M | 12.82M | 19.35M | 25.37M | 21.59M | 12.51M | 155.00K | 180.00K | 31.00K | 0.00 |
| Gross Profit | 3.68M | 12.05M | 32.43M | -3.60M | 10.66M | 10.64M | 9.48M | 6.16M | 3.33M | -23.94M | -20.49M | -12.14M | 563.00K | 31.00K | -11.00K | 0.00 |
| Gross Profit Ratio | 12.23% | 21.54% | 43.98% | -42.91% | 21.97% | 21.25% | 19.42% | 32.44% | 14.70% | -1,680.21% | -1,862.73% | -3,290.79% | 78.41% | 14.69% | -55.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 681.00K | 92.00K | 889.00K | 1.51M | 1.74M | 2.02M | 2.36M | 1.98M | 3.11M |
| General & Administrative | 12.96M | 31.17M | 24.20M | 15.94M | 14.32M | 16.24M | 16.58M | 12.86M | 9.62M | 16.37M | 40.37M | 10.23M | 2.78M | 2.07M | 1.57M | 1.41M |
| Selling & Marketing | 7.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.25M | 163.00K | -889.00K | 0.00 | 659.00K | 2.19M | 2.10M | 1.75M | 2.77M |
| SG&A | 20.91M | 31.17M | 24.20M | 15.94M | 14.32M | 16.24M | 16.58M | 14.11M | 10.38M | 15.48M | 40.37M | 10.89M | 4.97M | 4.17M | 3.32M | 4.18M |
| Other Expenses | 10.98M | 5.43M | 3.20M | 5.21M | 6.12M | 498.00K | -197.00K | 681.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 31.89M | 36.60M | 27.40M | 21.15M | 20.44M | 25.74M | 24.55M | 28.57M | 13.68M | 21.50M | 41.88M | 12.63M | 6.99M | 6.53M | 5.30M | 7.29M |
| Cost & Expenses | 58.32M | 80.49M | 68.70M | 33.13M | 58.30M | 65.19M | 63.90M | 41.39M | 33.03M | 46.86M | 41.88M | 25.14M | 7.14M | 6.71M | 5.33M | 7.29M |
| Interest Income | 448.00K | 384.00K | 43.00K | 1.83M | 2.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 321.00K | 16.13M | 0.00 | 1.83M | 2.90M | 1.83M | 731.00K | 1.70M | 2.59M | 0.00 | 0.00 | 0.00 | 1.53M | 4.30M | 617.00K | 157.00K |
| Depreciation & Amortization | 3.55M | 7.27M | 4.92M | 7.23M | 6.12M | 9.50M | 6.85M | 1.32M | 3.52M | 4.02M | 5.22M | 2.50M | 61.00K | 87.00K | 113.00K | 107.00K |
| EBITDA | -15.75M | -19.12M | 7.87M | -19.54M | -11.24M | -24.58M | -8.43M | -16.26M | -6.01M | -40.32M | -35.56M | -19.87M | -5.80M | -6.41M | -5.35M | -7.18M |
| EBITDA Ratio | -52.31% | -16.77% | 14.63% | -198.75% | -11.46% | -10.18% | -14.94% | -45.51% | -30.10% | 1,646.81% | -3,144.18% | -6,034.42% | -886.21% | -3,036.97% | -25,965.00% | 0.00% |
| Operating Income | -19.30M | -24.55M | 5.87M | -40.10M | -9.78M | -34.73M | -15.07M | -22.42M | -10.34M | -111.20M | -40.78M | -24.77M | -6.42M | -6.50M | -5.31M | -7.29M |
| Operating Income Ratio | -64.08% | -43.89% | 7.95% | -478.28% | -20.16% | -69.32% | -30.87% | -118.15% | -45.59% | -7,803.23% | -3,707.00% | -6,712.20% | -894.71% | -3,078.20% | -26,530.00% | 0.00% |
| Total Other Income/Expenses | -8.70M | -1.41M | -1.16M | -52.12M | -4.80M | -1.18M | -1.29M | -1.57M | -1.78M | 1.97M | -971.00K | 1.59M | -965.00K | -3.41M | -770.00K | -51.00K |
| Income Before Tax | -27.99M | -32.57M | 3.03M | -92.23M | -20.68M | -35.91M | -16.00M | -24.00M | -12.12M | -109.22M | -41.75M | -20.79M | -7.39M | -9.91M | -6.08M | -7.34M |
| Income Before Tax Ratio | -92.98% | -58.23% | 4.11% | -1,099.88% | -42.62% | -71.68% | -32.77% | -126.50% | -53.44% | -7,664.70% | -3,795.27% | -5,633.06% | -1,029.11% | -4,695.26% | -30,380.00% | 0.00% |
| Income Tax Expense | 35.00K | 55.00K | 140.00K | 7.00K | -146.00K | -278.00K | 111.00K | 13.64M | -866.00K | 65.34M | 11.66M | 55.00K | 90.00K | 35.00K | 73.00K | -7.00K |
| Net Income | -27.74M | -32.63M | 3.35M | -92.23M | -20.53M | -37.21M | -28.84M | -24.01M | -11.16M | -109.68M | -52.43M | -20.84M | -7.48M | -9.94M | -6.15M | -7.33M |
| Net Income Ratio | -92.14% | -58.33% | 4.54% | -1,099.96% | -42.32% | -74.27% | -59.07% | -126.52% | -49.18% | -7,696.63% | -4,766.64% | -5,647.97% | -1,041.64% | -4,711.85% | -30,745.00% | 0.00% |
| EPS | -6.64 | -6.97 | 0.60 | -41.39 | -251.22 | -1.54K | -1.55K | -1.90K | -1.31K | -14.68K | -7.56K | -6.39K | -9.02K | -22.09K | -2.57 | -7.02K |
| EPS Diluted | -6.64 | -6.97 | 0.60 | -41.39 | -251.22 | -1.54K | -1.55K | -1.90K | -1.31K | -14.55K | -7.56K | -6.00K | -9.02K | -22.09K | -2.57 | -7.02K |
| Weighted Avg Shares Out | 4.18M | 4.68M | 5.22M | 2.23M | 81.72K | 24.23K | 18.57K | 12.64K | 8.51K | 7.47K | 6.93K | 3.26K | 829.00 | 450.00 | 2.39M | 1.05K |
| Weighted Avg Shares Out (Dil) | 4.18M | 4.68M | 5.25M | 2.23M | 81.72K | 24.23K | 18.57K | 12.64K | 8.51K | 7.54K | 6.94K | 3.47K | 829.00 | 450.00 | 2.39M | 1.05K |
XWELL Announces Closing of $1.4 Million Registered Direct Offering Priced At Premium to Market
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced the closing of its previously announced registered direct offering priced at a...
CPC Issues Letter to Fellow XWELL, Inc. Shareholders Revealing Intention Behind Recent Schedule 13D Filing & Lawsuit Against Entrenched Board of Directors
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Today, CPC Pain & Wellness SPV, LLC (“CPC”), a significant XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”) shareholder that beneficially owns 394,200 or 9.42% of XWELL's outstanding shares, issued the below...
XWELL Announces Director Candidate Nomination Notice Submitted by CPC is Invalid
NEW YORK--(BUSINESS WIRE)--XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced that the notice materials submitted by CPC Pain & Wellness SPV, LLC (“CPC”), which purported to provide notice...
XWELL Opens New XpresSpa Location at Philadelphia International Airport
New location expands domestic footprint in busy Northeast corridor with labor lite tech forward service offerings New location expands domestic footprint in busy Northeast corridor with labor lite tech forward service offerings
XWELL Continues to Innovate in Airport Wellness Space with New Massage Solutions: Introducing Ceragem V6 in select XpresSpa® Locations in US
Expanded service offering underscores XWELL's ongoing focus on delivering cost-effective wellness services that drive top-line growth Expanded service offering underscores XWELL's ongoing focus on delivering cost-effective wellness services that drive top-line growth
XWELL, Inc. Reports First Quarter 2024 Results
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the first quarter ended March 31, 2024.
XpresSpa Introduces IV Hydration Drip Therapy at Miami International Airport
Pilot program designed to expand service offerings and drive revenue growth Pilot program designed to expand service offerings and drive revenue growth
XWELL, Inc. (XWEL) Q4 2023 Earnings Call Transcript
XWELL, Inc. (XWEL) Q4 2023 Earnings Call Transcript
XWELL, Inc. Reports Fiscal Year 2023 Results
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the year ended December 31, 2023.
XWELL, Inc. to Report Fiscal Year 2023 Financial Results on Tuesday, April 16, 2024
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced that it will report results for the year ended December 31, 2023,...
Source: https://incomestatements.info
Category: Stock Reports